Cargando…

Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement

Introduction: Acquired factor V inhibitor (AFVI) is a rare autoimmune bleeding disorder. The treatment of AFVI is challenging, and patients often require both bleeding control and inhibitor eradication. Methods: We conducted a retrospective analysis of the medical records of a 35-year-old Caucasian...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ceglédi, Andrea, Dolgos, János, Fekete, Mónika, Gopcsa, László, Várkonyi, Andrea, Vilimi, Beáta, Mikala, Gábor, Bodó, Imre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272408/ https://www.ncbi.nlm.nih.gov/pubmed/37334173 http://dx.doi.org/10.3389/pore.2023.1611250

Ejemplares similares

P1658: DELAYED REVERSAL OF FACTOR V INHIBITOR ACTIVITY POST-IMMUNOSUPPRESSIVE THERAPY, FOLLOWED BY A SUCCESSFUL PREGNANCY: A CASE REPORT
por: Cegledi, A., et al.
Publicado: (2022)

Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14)
por: Ceglédi, Andrea, et al.
Publicado: (2023)

Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen
por: Simon, Barbara, et al.
Publicado: (2022)

Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary
por: Lovas, Szilvia, et al.
Publicado: (2022)

Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry
por: Takács, Ferenc, et al.
Publicado: (2022)

Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers
por: Szita, Virág Réka, et al.
Publicado: (2022)

Radiotherapy of Breast Cancer—Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Polgár, Csaba, et al.
Publicado: (2022)

Percutaneous tracheostomy: Comparison of three different methods with respect to tracheal cartilage injury in cadavers—Randomized controlled study
por: Bódis, Fruzsina, et al.
Publicado: (2023)

Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features
por: Turkevi-Nagy, Sándor, et al.
Publicado: (2021)

Case Report: A Child With Hemophilia A Serves as Donor for Hematopoietic Stem Cell Transplantation to Cure His Brother’s Severe Aplastic Anemia
por: Kertész, Gabriella, et al.
Publicado: (2022)

Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment
por: Urban, Veronika S., et al.
Publicado: (2022)

The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients
por: Kispál, Mihály, et al.
Publicado: (2022)

Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer
por: Wang, Jie, et al.
Publicado: (2022)

Patient delay and its clinical significance among head and neck cancer patients in Hungary
por: Dános, Kornél, et al.
Publicado: (2023)

Grade Group accuracy is improved by extensive prostate biopsy sampling, but unrelated to prostatectomy specimen sampling or use of immunohistochemistry
por: Korpás, Kristóf Levente, et al.
Publicado: (2023)

Case Report: Brainstem angiocentric glioma presenting in a toddler child–diagnostic and therapeutic challenges
por: Reisz, Zita, et al.
Publicado: (2023)

Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data
por: Revesz, Janos, et al.
Publicado: (2023)

Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma
por: Gyulai, Marton, et al.
Publicado: (2023)

PD-1 and PD-L1 expression in rare lung tumors
por: Gyulai, Marton, et al.
Publicado: (2023)

Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma: Real World Experience of a Single Center
por: Kopińska, A., et al.
Publicado: (2021)

Novel Diagnostic Value of Driver Gene Transcription Signatures to Characterise Clear Cell Renal Cell Carcinoma, ccRCC
por: Ujfaludi, Zsuzsanna, et al.
Publicado: (2022)

Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor
por: Radeczky, Peter, et al.
Publicado: (2021)

Case report: Relapsed/refractory extranodal natural killer/T-cell lymphoma nasal type with extensive central nervous system involvement
por: Dapkevičiūtė-Purlienė, Austėja, et al.
Publicado: (2023)

EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of Results in a Three-Year Period and a Comparison of Commercially Available Detection Kits
por: Bencze, Eszter, et al.
Publicado: (2022)

Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy
por: Pfaendler, Krista S, et al.
Publicado: (2022)

Intracystic endometrioid borderline tumor
por: El Hajj, Houssein, et al.
Publicado: (2023)

Analysis of Ionizing Radiation Induced DNA Damage by Superresolution dSTORM Microscopy
por: Brunner, Szilvia, et al.
Publicado: (2021)

Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Cserni, Gábor, et al.
Publicado: (2022)

The Activation of PDGFRβ on Mononuclear Stromal/Tumor Cells in Giant Cell Tumor of Bone After Denosumab Treatment. An Immunohistochemical Study of Five Cases
por: Antal, Imre, et al.
Publicado: (2022)

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia
por: Kövy, Petra, et al.
Publicado: (2021)

Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University
por: Ferenczi, Kata, et al.
Publicado: (2023)

Editorial: Guidelines From the Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Kulka, Janina, et al.
Publicado: (2022)

Beneficial Effect of Lenalidomide-Dexamethason Treatment in Relapsed/Refractory Multiple Myeloma Patients: Results of Real-Life Data From 11 Hungarian Centers
por: Varga, Gergely, et al.
Publicado: (2021)

On-Target Side Effects of Targeted Therapeutics of Cancer
por: Tímár, József, et al.
Publicado: (2022)

Anastomosing Haemangioma: Report of Three Cases With Molecular and Immunohistochemical Studies and Comparison With Well-Differentiated Angiosarcoma
por: Chang Chien, Yi-Che, et al.
Publicado: (2022)

Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary
por: Müller, Judit, et al.
Publicado: (2022)

Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
por: Forika, Gertrud, et al.
Publicado: (2021)

A new perspective on the proper timing of radiotherapy during CDK4/6 inhibitor therapy in patients with “bone-only” metastatic breast cancer
por: Tornyi, Ilona, et al.
Publicado: (2023)

Comparison of Shear Wave Elastography and Dynamometer Test in Muscle Tissue Characterization for Potential Medical and Sport Application
por: Soldos, Peter, et al.
Publicado: (2021)

Is Single Nucleotide Polymorphism ADIPOQ (NM_004797.4):c.214+62G>T (rs1501299) Associated With Uterine Leiomyomas? A Pilot Study
por: Bieńkiewicz, Jan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3qreuptbn6voch2saimjbbbh42